Tag : Evogene

CCT Impact

Evogene Announces Participation in the Second Research Period of the CRISPR-IL Consortium

CCT IMPACT Agent
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today that it has been informed by the Israeli Innovation Authority (IIA) of the IIA’s decision to fund a second 18-month period of the CRISPR-IL consortium established last year.......
CCT Impact

Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2021

CCT IMPACT Agent
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the third quarter of 2021 on Wednesday, November 17th, 2021. Dr. Arnon Heyman, CEO of Canonic Ltd., Evogene’s subsidiary, will be joining the......
CCT Impact

Evogene Reports Second Quarter 2021 Financial Results

CCT IMPACT Agent
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across several market segments, announced today its financial results for the first half and the second quarter of 2021, ended June 30, 2021. Mr. Ofer Haviv, Evogene’s President and Chief Executive Officer, stated, “As Evogene’s......
CCT Impact

Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2021

CCT IMPACT Agent
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the second quarter of 2021 on Wednesday, August 11th, 2021. Ms. Sarit Firon Evogene’s incoming Chairperson of the Board, will join the......
CCT Impact

Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2020

CCT IMPACT Agent
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the third quarter of 2020 on Wednesday, November 18, 2020. Dr. Elran Haber, CEO of Evogene’s human microbiome subsidiary, Biomica Ltd., will join......
Market Watch

Evogene Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)

CCT IMPACT Agent
Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN.TA), a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, today announced it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference.  The conference is being held on September......
CCT Impact

Evogene Reports Second Quarter 2020 Financial Results

CCT IMPACT Agent
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its financial results for the second quarter ended June 30, 2020. Ofer Haviv, Evogene’s President and CEO, stated: “During the second quarter the company announced its new branding, which marks the......